Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

NT Ihle, LA Byers, ES Kim, P Saintigny… - Journal of the …, 2012 - academic.oup.com
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.

NT Ihle, LA Byers, ES Kim, P Saintigny… - Journal of the …, 2012 - europepmc.org
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

Effect of KRAS oncogene substitutions on protein behavior: Implications for signaling and clinical outcome

NT Ihle, LA Byers, ES Kim… - Journal of the …, 2012 - utsouthwestern.elsevierpure.com
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

Effect of KRAS oncogene substitutions on protein behavior: Implications for signaling and clinical outcome

NT Ihle, LA Byers, ES Kim… - Journal of the …, 2012 - ohiostate.elsevierpure.com
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

[HTML][HTML] Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

NT Ihle, LA Byers, ES Kim, P Saintigny… - JNCI Journal of the …, 2012 - ncbi.nlm.nih.gov
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

NT Ihle, LA Byers, ES Kim… - Journal of the …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome.

NT Ihle, LA Byers, ES Kim, P Saintigny… - JNCI: Journal of the …, 2012 - search.ebscohost.com
Background Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …

[引用][C] Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

NT IHLE, LA BYERS, L DIAO… - Journal of the …, 2012 - pascal-francis.inist.fr
Author IHLE, Nathan T 1; BYERS, Lauren A 2; LIXIA DIAO 3; COOMBES, Kevin R 3; LU
CHEN 1; SHUXING ZHANG 1; ABDELMELEK, Mena F 1; XIMING TANG 2; …

[引用][C] Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee… - JNCI: Journal of the …, 2012 - cir.nii.ac.jp

[引用][C] Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

NT Ihle, LA Byers, ES Kim… - Journal of the …, 2012 - espace.library.uq.edu.au
Background: Mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
play a critical role in cancer cell growth and resistance to therapy. Most mutations occur at …